Business Standard

WHO plans slew of coronavirus vaccine approvals for global rollout

COVAX, a global scheme co-led by the WHO, wants to deliver at least 2 billion Covid-19 doses across the world this year, with at least 1.3 billion going to poorer countries

WHO plans slew of coronavirus vaccine approvals for global rollout
Premium

The Covid-19 vaccine developed by AstraZeneca and manufactured by the Serum Institute of India (SII) could be authorised by the WHO in January or February, the document says

Reuters
The World Health Organization (WHO) plans to approve several Covid-19 vaccines from Western and Chinese manufacturers in coming weeks and months, a document published on Wednesday shows, as it aims for rapid rollouts in poorer countries.
 
COVAX, a global scheme co-led by the WHO, wants to deliver at least 2 billion Covid-19 doses across the world this year, with at least 1.3 billion going to poorer countries.
 
But it has so far struggled to secure enough shots due to a shortage of funds, while wealthy nations have booked large volumes of vaccines for themselves.
 
In the race to deploy shots,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in